PHAR
Pharming Group N.V.
NASDAQ · Healthcare · Biotechnology · NL
$11.23
−2.01%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-10.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 12, 2004 | CAMDEN PARTNERS STRATEGIC FUND II A LP · other: See General Remarks and FN 1 | A-Award | 5,000 | $0.68 |
Institutional positioning
13F filings over the trailing two quarters
New 13Increased 3Reduced 13Sold out 3
| Filer | Action | Shares | Filed |
|---|---|---|---|
| MAC Alpha Capital Management, LP | New Position | 2,148,144 | Aug 14, 2026 |
| SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC | Reduced | 44,747 | Apr 16, 2026 |
| Silverberg Bernstein Capital Management LLC | Reduced | 41,547 | Jul 7, 2026 |
| Crossmark Global Holdings, Inc. | New Position | 12,463 | Jul 16, 2026 |
| CITADEL ADVISORS LLC | Increased | 11,972 | Sep 2, 2026 |
| MORGAN STANLEY | Increased | 11,500 | Aug 13, 2026 |
| MORGAN STANLEY | Reduced | 11,489 | May 15, 2026 |
| SmartHarvest Portfolios, LLC | Reduced | 10,797 | Apr 21, 2026 |
| SmartHarvest Portfolios, LLC | Reduced | 10,415 | Aug 4, 2026 |
| CITADEL ADVISORS LLC | Reduced | 10,189 | May 15, 2026 |
| Knoll Capital Management, LLC | Increased | 4,091 | Aug 14, 2026 |
| KNOLL CAPITAL MANAGEMENT, LLC | New Position | 4,057 | May 15, 2026 |
| NEWEDGE ADVISORS, LLC | Reduced | 2,150 | Jun 3, 2026 |
| Silver Grove Financial Group, Inc. | New Position | 1,071 | Aug 13, 2026 |
| Nalls Sherbakoff Group, LLC | Unchanged | 870 | Aug 17, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 12, 2004